Meher B. Gayatri
Hyderabad, TG, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
AMPK-induced novel phosphorylation of RUNX1 inhibits STAT3 activation and overcome imatinib resistance in chronic myelogenous leukemia (CML) subjects.
Journal: Cell death discovery
Published: August 29, 2023
A gain-of-function p53 mutant synergizes with oncogenic NRAS to promote acute myeloid leukemia in mice.
Journal: The Journal of clinical investigation
Published: June 21, 2023
Involvement of Target of Rapamycin (TOR) Signaling in the Regulation of Crosstalk between Ribosomal Protein Small Subunit 6 Kinase-1 (RPS6K-1) and Ribosomal Proteins.
Journal: Plants (Basel, Switzerland)
Published: November 28, 2022
Metformin exerts antileukemic effects by modulating lactate metabolism and overcomes imatinib resistance in chronic myelogenous leukemia.
Journal: The FEBS journal
Published: August 09, 2022
High glutamine suppresses osteogenesis through mTORC1-mediated inhibition of the mTORC2/AKT-473/RUNX2 axis.
Journal: Cell death discovery
Published: April 09, 2022
Analysis of cellular models of clonal evolution reveals co-evolution of imatinib and HSP90 inhibitor resistances.
Journal: Biochemical and biophysical research communications
Published: October 13, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026